BONUS: How Effective Are Antibody Treatments For COVID-19?
Consider This from NPR
NPR
4.2 • 6.2K Ratings
🗓️ 13 December 2020
⏱️ 12 minutes
🧾️ Download transcript
Summary
In this episode of Short Wave, NPR's daily science podcast, science correspondent Richard Harris explains how the new treatments work — and whether they could really make a difference for patients with COVID-19.
Listen to more episodes of Short Wave on Apple Podcasts or Spotify.
See pcm.adswizz.com for information about our collection and use of personal data for sponsorship and to manage your podcast sponsorship preferences.
NPR Privacy Policy
Transcript
Click on a timestamp to play from that location
| 0:00.0 | Hi, consider this listener's Mary Louise Kelly here. |
| 0:03.3 | It is Sunday, which means we've got a bonus episode for you. |
| 0:07.0 | It comes from our colleagues at NPR's Daily Science podcast, Shortwave. |
| 0:12.0 | With a coronavirus vaccine still months away for most Americans, they took a look at a new |
| 0:17.3 | therapy that could help some people who get sick with COVID-19. |
| 0:21.5 | There's a link in our episode notes where you can subscribe to or follow Shortwave on Apple |
| 0:26.2 | Podcasts or Spotify to hear about new discoveries and everyday mysteries and the science behind |
| 0:32.4 | the headlines. |
| 0:33.4 | Here is Shortwave host, Maddie Sophia. |
| 0:40.8 | Maddie Sophia here with science correspondent Richard Harris Hyrichard. |
| 0:43.8 | Hey, Maddie. |
| 0:45.6 | So COVID vaccines have been getting a ton of attention lately. |
| 0:50.0 | But you're here to talk to us about a treatment for COVID that was recently authorized. |
| 0:54.7 | That's right, last month. |
| 0:56.6 | Another critical breakthrough in the fight against a coronavirus. |
| 0:59.8 | The FDA cleared Regeneron's antibody treatment for emergency use, giving patients- |
| 1:04.8 | FDA has authorized emergency use of the first antibody drug to help the immune system fight |
| 1:10.2 | COVID-19. |
| 1:11.6 | The drug from Eli Lilly is cleared for people. |
| 1:14.4 | So we've got two now, one from the drug company Regeneron and one from the drug company |
| 1:18.3 | Eli Lilly. |
| 1:19.4 | Both Regeneron and Eli Lilly are currently testing the treatments on humans and clinical |
... |
Please login to see the full transcript.
Disclaimer: The podcast and artwork embedded on this page are from NPR, and are the property of its owner and not affiliated with or endorsed by Tapesearch.
Generated transcripts are the property of NPR and are distributed freely under the Fair Use doctrine. Transcripts generated by Tapesearch are not guaranteed to be accurate.
Copyright © Tapesearch 2026.